Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Hamadani

Showing results (111-120 of 460) with videos related to

Pageof 46
Sort By:
Current Hematologic Malignancy Reports|May 19, 2021
Enteropathy-Associated T cell LymphomaZakiah Al Somali, Mehdi Hamadani, Mohamed Kharfan-Dabaja, et al.
Annals of Hematology|October 8, 2013
Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipientsQuoc Truong, Lauren Veltri, Abraham S Kanate, et al.
Bone Marrow Transplantation|July 15, 2021
Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysisRamzi Abboud, Fei Wan, Jacopo Mariotti, et al.
Journal of Hematology & Oncology|January 8, 2013
Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trialsMohamed A Kharfan-Dabaja, Mehdi Hamadani, Tea Reljic, et al.
Journal of Clinical Apheresis|June 15, 2013
Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSFLubna Chaudhary, Farrukh Awan, Aaron Cumpston, et al.
Journal of Oncology|May 10, 2012
Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell MobilizationFarrukh T Awan, S Thomas Kochuparambil, David Deremer, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 18, 2007
Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?Mehdi Hamadani, Lubna Chaudhary, Farrukh T Awan, et al.
European Journal of Haematology|September 9, 2008
High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphomaMehdi Hamadani, Don M Benson, Thomas S Lin, et al.
American Journal of Hematology|August 19, 2015
Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosisAmara S Hussain, Parameswaran Hari, Ruta Brazauskas, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2024
Immunoglobulin High Throughput Sequencing (Ig-HTS) Minimal Residual Disease (MRD) Analysis is an Effective Surveillance Tool in Patients With Mantle Cell LymphomaAlexandra Rezazadeh, Julie Pruett, Amy Detzner, et al.
Pageof 46

Showing results (111-120 of 460) with videos related to

Sort By:
Pageof 46
Current Hematologic Malignancy Reports|May 19, 2021
Enteropathy-Associated T cell LymphomaZakiah Al Somali, Mehdi Hamadani, Mohamed Kharfan-Dabaja, et al.
Annals of Hematology|October 8, 2013
Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipientsQuoc Truong, Lauren Veltri, Abraham S Kanate, et al.
Bone Marrow Transplantation|July 15, 2021
Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysisRamzi Abboud, Fei Wan, Jacopo Mariotti, et al.
Journal of Hematology & Oncology|January 8, 2013
Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trialsMohamed A Kharfan-Dabaja, Mehdi Hamadani, Tea Reljic, et al.
Journal of Clinical Apheresis|June 15, 2013
Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSFLubna Chaudhary, Farrukh Awan, Aaron Cumpston, et al.
Journal of Oncology|May 10, 2012
Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell MobilizationFarrukh T Awan, S Thomas Kochuparambil, David Deremer, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 18, 2007
Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?Mehdi Hamadani, Lubna Chaudhary, Farrukh T Awan, et al.
European Journal of Haematology|September 9, 2008
High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphomaMehdi Hamadani, Don M Benson, Thomas S Lin, et al.
American Journal of Hematology|August 19, 2015
Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosisAmara S Hussain, Parameswaran Hari, Ruta Brazauskas, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2024
Immunoglobulin High Throughput Sequencing (Ig-HTS) Minimal Residual Disease (MRD) Analysis is an Effective Surveillance Tool in Patients With Mantle Cell LymphomaAlexandra Rezazadeh, Julie Pruett, Amy Detzner, et al.
Pageof 46